chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sick with everything; diarrhea; Feeling worse than when I had Covid-19; body aches; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick with everything), DIARRHOEA (diarrhea), FEELING ABNORMAL (Feeling worse than when I had Covid-19), MYALGIA (body aches) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart disorder. Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D), APIXABAN (ELIQUIS), FUROSEMIDE, Vastalic, Nitrofurantoin                                                 once a day, PANTOPRAZOLE, POTASSIUM CHLORIDE, SPIRONOLACTONE and ZOLPIDEM for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced ILLNESS (sick with everything), DIARRHOEA (diarrhea), FEELING ABNORMAL (Feeling worse than when I had Covid-19), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (sick with everything), DIARRHOEA (diarrhea), FEELING ABNORMAL (Feeling worse than when I had Covid-19), MYALGIA (body aches), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Maternal exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (4 drinks/week) from 2010 to 20-Aug-2020. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 04-Aug-2020 and the estimated date of delivery was 11-May-2021. On 19-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy. The delivery occurred  on 22-May-2021, which was reported as Full-term. For neonate 1, the birth weight was 3380 grams (7lbs 7oz). The outcome was reported as Term Birth NOS. Live, full-term birth Male baby. Fetus/Infant length: 51 cm, Head circumference: 15 cm. No perinatal complications observed in the infant. No fetal/infant abnormalities identified on delivery. Baby's APGAR score was not known but baby was normal. On 19-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Aug-2020, Pregnancy test: positive (Positive) positive. On 14-Dec-2020, Ultrasound scan: normal (normal) Normal. On 20-Mar-2021, Blood glucose: negative (Negative) Negative. On 10-Apr-2021, Ultrasound scan: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.    Patient (mother) did not have a history of subfertility. There were no pregnancy-related complications or other acute illnesses. Patient (mother) did not have any problems during a delivery.   This case was linked to MOD-2021-272297 (Parent-Child Link).   See case MOD-2021-272297 for details regarding the child case.  Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Pregnancy Information , Medical history and Lab data updated. Vaccine dose details and action taken with drug updated.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm as usual which is normal; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm as usual which is normal) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm as usual which is normal). At the time of the report, PAIN IN EXTREMITY (Sore arm as usual which is normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal hypermotility, Heart rate increased, Hot flush
Clinical narrative: rapid heartbeat; hot flash; in need to make a bowel movement; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heartbeat), HOT FLUSH (hot flash) and GASTROINTESTINAL HYPERMOTILITY (in need to make a bowel movement) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Allergy to antibiotic.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced HEART RATE INCREASED (rapid heartbeat), HOT FLUSH (hot flash) and GASTROINTESTINAL HYPERMOTILITY (in need to make a bowel movement). On 31-Mar-2021, HEART RATE INCREASED (rapid heartbeat), HOT FLUSH (hot flash) and GASTROINTESTINAL HYPERMOTILITY (in need to make a bowel movement) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever at 102; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever at 102) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever at 102). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever at 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Blood pressure measurement: 175/110 (High) 175/110 and 161/99 161/99. In February 2021, Heart rate: 157 bpm (High) 157 bpm. In February 2021, SARS-CoV-2 test: negative (Negative) Negative.         Concomitant medication was not provided.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Constipation, Neck pain, Toothache, Vaccination site pain
Clinical narrative: Constipation has got worse; Has a sore arm; Sore neck/very painful; All of his teeth were sore; This spontaneous case was reported by a consumer and describes the occurrence of CONSTIPATION (Constipation has got worse), VACCINATION SITE PAIN (Has a sore arm), NECK PAIN (Sore neck/very painful) and TOOTHACHE (All of his teeth were sore) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history reported). Concomitant products included MACROGOL 3350 (MIRALAX) for an unknown indication.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced CONSTIPATION (Constipation has got worse), VACCINATION SITE PAIN (Has a sore arm), NECK PAIN (Sore neck/very painful) and TOOTHACHE (All of his teeth were sore). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, CONSTIPATION (Constipation has got worse), VACCINATION SITE PAIN (Has a sore arm), NECK PAIN (Sore neck/very painful) and TOOTHACHE (All of his teeth were sore) had not resolved.            The treatment medications includes roller ball with 5% menthol which helped also.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Swelling face
Clinical narrative: Shortness of breath, a little tightening; Some swelling in face, looks a little swollen; Headache; Uncomfortable in her chest/Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Uncomfortable in her chest/Chest pain), DYSPNOEA (Shortness of breath, a little tightening), SWELLING FACE (Some swelling in face, looks a little swollen) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder (she has 16 stents.). Concomitant products included fibromyalgia for Fibromyalgia.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced CHEST PAIN (Uncomfortable in her chest/Chest pain). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath, a little tightening), SWELLING FACE (Some swelling in face, looks a little swollen) and HEADACHE (Headache). The patient was treated with NITROGLYCERIN for Chest pain, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Uncomfortable in her chest/Chest pain), DYSPNOEA (Shortness of breath, a little tightening), SWELLING FACE (Some swelling in face, looks a little swollen) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Hot to Touch Sensation - Near Injection Site; Bumps - Near Injection Site; Sore Arm; Itchy Sensation - Near Injection Site; Redness - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE MASS (Bumps - Near Injection Site), PAIN IN EXTREMITY (Sore Arm), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site) and VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE MASS (Bumps - Near Injection Site), PAIN IN EXTREMITY (Sore Arm), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site) and VACCINATION SITE ERYTHEMA (Redness - Near Injection Site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near Injection Site), VACCINATION SITE MASS (Bumps - Near Injection Site), PAIN IN EXTREMITY (Sore Arm), VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site) and VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Erythema, Incorrect route of product administration, Swelling
Clinical narrative: Big bruising for more than 10 days; Red swelling lump for several days; Red swelling lump for several days; First injection on his left arm was administered not intramuscularly but subcutaneous; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (First injection on his left arm was administered not intramuscularly but subcutaneous), CONTUSION (Big bruising for more than 10 days), SWELLING (Red swelling lump for several days) and ERYTHEMA (Red swelling lump for several days) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Lipoma and Surgery (Had previously surgery because of lipoma on left arm and it can cause the difficulty during administration.). Concomitant products included METOPROLOL, VALSARTAN, ATORVASTATIN, PREDNISONE, AMPICILLIN and ACETYLSALICYLIC ACID (ASPIRINE) for an unknown indication, LEVOTHYROXINE.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (First injection on his left arm was administered not intramuscularly but subcutaneous), SWELLING (Red swelling lump for several days) and ERYTHEMA (Red swelling lump for several days). On 23-Jan-2021, the patient experienced CONTUSION (Big bruising for more than 10 days). On 21-Jan-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (First injection on his left arm was administered not intramuscularly but subcutaneous) had resolved. On 03-Mar-2021, CONTUSION (Big bruising for more than 10 days) had resolved. On 25-Mar-2021, SWELLING (Red swelling lump for several days) and ERYTHEMA (Red swelling lump for several days) had resolved.    Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Severe intermittent arthralgia; Body and head aches; Body and head aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (Severe intermittent arthralgia), MYALGIA (Body and head aches) and HEADACHE (Body and head aches) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L02A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced ARTHRALGIA (Severe intermittent arthralgia), MYALGIA (Body and head aches) and HEADACHE (Body and head aches). At the time of the report, ARTHRALGIA (Severe intermittent arthralgia), MYALGIA (Body and head aches) and HEADACHE (Body and head aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. After the second dose of the Moderna Covid vaccine He started experiencing severe intermittent arthralgia that caused him a lot of difficulties on his daily life. He is under medical treatment. Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Body and Head aches; Body and Head aches; This spontaneous case was reported by a health care professional and describes the occurrence of MYALGIA (Body and Head aches) and HEADACHE (Body and Head aches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L02A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced MYALGIA (Body and Head aches) and HEADACHE (Body and Head aches). On 12-Feb-2021, MYALGIA (Body and Head aches) and HEADACHE (Body and Head aches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was reported. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-072104 (Patient Link).
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Illness, Urticaria
Clinical narrative: diarrhea; covered with hives all over her body; felt really sick; arm started itching; big red patch at the injection site; vomiting; massive headache; tired; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), URTICARIA (covered with hives all over her body), ILLNESS (felt really sick), VACCINATION SITE PRURITUS (arm started itching) and VACCINATION SITE ERYTHEMA (big red patch at the injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FATIGUE (tired) and VACCINATION SITE PAIN (arm pain). On 18-Mar-2021, the patient experienced DIARRHOEA (diarrhea), URTICARIA (covered with hives all over her body), ILLNESS (felt really sick), VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (big red patch at the injection site), VOMITING (vomiting) and HEADACHE (massive headache). The patient was treated with CETIRIZINE at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 10-Mar-2021, VACCINATION SITE PAIN (arm pain) had resolved. On 23-Mar-2021, DIARRHOEA (diarrhea), URTICARIA (covered with hives all over her body), ILLNESS (felt really sick), VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (big red patch at the injection site), VOMITING (vomiting), HEADACHE (massive headache) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vomiting
Clinical narrative: diarrhea; covered with hives all over her body; felt really sick; arm started itching; big red patch at the injection site; vomiting; massive headache; tired; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), URTICARIA (covered with hives all over her body), ILLNESS (felt really sick), VACCINATION SITE PRURITUS (arm started itching) and VACCINATION SITE ERYTHEMA (big red patch at the injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced FATIGUE (tired) and VACCINATION SITE PAIN (arm pain). On 18-Mar-2021, the patient experienced DIARRHOEA (diarrhea), URTICARIA (covered with hives all over her body), ILLNESS (felt really sick), VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (big red patch at the injection site), VOMITING (vomiting) and HEADACHE (massive headache). The patient was treated with CETIRIZINE at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 10-Mar-2021, VACCINATION SITE PAIN (arm pain) had resolved. On 23-Mar-2021, DIARRHOEA (diarrhea), URTICARIA (covered with hives all over her body), ILLNESS (felt really sick), VACCINATION SITE PRURITUS (arm started itching), VACCINATION SITE ERYTHEMA (big red patch at the injection site), VOMITING (vomiting), HEADACHE (massive headache) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (headache). At the time of the report, NAUSEA (Nausea) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Product dose omission issue
Clinical narrative: Missed second dose; Covid-19; Cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), COVID-19 (Covid-19) and PRODUCT DOSE OMISSION ISSUE (Missed second dose) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced COUGH (Cough). On 30-Mar-2021, the patient experienced COVID-19 (Covid-19). On 01-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose). At the time of the report, COUGH (Cough), COVID-19 (Covid-19) and PRODUCT DOSE OMISSION ISSUE (Missed second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. The patient did not receive any treatment.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: jolt in the arm when the injection was done; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (jolt in the arm when the injection was done) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PAIN (jolt in the arm when the injection was done). At the time of the report, VACCINATION SITE PAIN (jolt in the arm when the injection was done) outcome was unknown.            Half an hour later, her arm started to hurt more than ever. It hurt so bad that she had tears in her eyes and she couldn't even lift her arm. She states "I was in a terrible amount of pain."  Concomitant medications were not reported. Treatment details not provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Mastectomy, Product dose omission issue
Clinical narrative: Bilateral mastectomy; Missed the 2nd vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the 2nd vaccination) and MASTECTOMY (Bilateral mastectomy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031620A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the 2nd vaccination). On an unknown date, the patient experienced MASTECTOMY (Bilateral mastectomy). On 11-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Missed the 2nd vaccination) had resolved. At the time of the report, MASTECTOMY (Bilateral mastectomy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Chills; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 01-Apr-2021, the patient experienced CHILLS (Chills), FATIGUE (Tired) and HEADACHE (Headache). On 02-Apr-2021, CHILLS (Chills) and FATIGUE (Tired) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient devolved a rash within 5 minutes of receiving the first dose. Concomitant medications were not reported. The patient was treated with Benadryl (diphenhydramine).  Company Comment: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia, Feeling abnormal, Headache, Hyperhidrosis, Myalgia
Clinical narrative: major headaches, heart burns and body aches; major headaches, heart burns and body aches; At 11am today, the patient stated that he started feeling worse.; major headaches, heart burns and body aches; Fever; covered himself with 4 covers and broke into sweats; This spontaneous case was reported by a consumer and describes the occurrence of Fever, HYPERHIDROSIS (covered himself with 4 covers and broke into sweats), HEADACHE (major headaches, heart burns and body aches), DYSPEPSIA (major headaches, heart burns and body aches) and MYALGIA (major headaches, heart burns and body aches) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced Fever and HYPERHIDROSIS (covered himself with 4 covers and broke into sweats). On 01-Apr-2021, the patient experienced HEADACHE (major headaches, heart burns and body aches), MYALGIA (major headaches, heart burns and body aches) and FEELING ABNORMAL (At 11am today, the patient stated that he started feeling worse.). On an unknown date, the patient experienced DYSPEPSIA (major headaches, heart burns and body aches). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, Fever was resolving and HYPERHIDROSIS (covered himself with 4 covers and broke into sweats), HEADACHE (major headaches, heart burns and body aches), DYSPEPSIA (major headaches, heart burns and body aches), MYALGIA (major headaches, heart burns and body aches) and FEELING ABNORMAL (At 11am today, the patient stated that he started feeling worse.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: major headaches, heart burns and body aches; major headaches, heart burns and body aches; At 11am today, the patient stated that he started feeling worse.; major headaches, heart burns and body aches; Fever; covered himself with 4 covers and broke into sweats; This spontaneous case was reported by a consumer and describes the occurrence of Fever, HYPERHIDROSIS (covered himself with 4 covers and broke into sweats), HEADACHE (major headaches, heart burns and body aches), DYSPEPSIA (major headaches, heart burns and body aches) and MYALGIA (major headaches, heart burns and body aches) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced Fever and HYPERHIDROSIS (covered himself with 4 covers and broke into sweats). On 01-Apr-2021, the patient experienced HEADACHE (major headaches, heart burns and body aches), MYALGIA (major headaches, heart burns and body aches) and FEELING ABNORMAL (At 11am today, the patient stated that he started feeling worse.). On an unknown date, the patient experienced DYSPEPSIA (major headaches, heart burns and body aches). The patient was treated with IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, Fever was resolving and HYPERHIDROSIS (covered himself with 4 covers and broke into sweats), HEADACHE (major headaches, heart burns and body aches), DYSPEPSIA (major headaches, heart burns and body aches), MYALGIA (major headaches, heart burns and body aches) and FEELING ABNORMAL (At 11am today, the patient stated that he started feeling worse.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Pyrexia
Clinical narrative: fever; extreme stomach pain; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (extreme stomach pain), DIARRHOEA (diarrhea) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (extreme stomach pain) and DIARRHOEA (diarrhea). On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, ABDOMINAL PAIN UPPER (extreme stomach pain), DIARRHOEA (diarrhea) and PYREXIA (fever) outcome was unknown.            No concomitant medication reported  No treatment information was provided   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in jaw
Clinical narrative: Pain on right side of jaw; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and PAIN IN JAW (Pain on right side of jaw) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), METFORMIN and DULAGLUTIDE (TRULICITY) for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 01-Apr-2021, the patient experienced PAIN IN JAW (Pain on right side of jaw). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea) and PAIN IN JAW (Pain on right side of jaw) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling of body temperature change, Hyperhidrosis, Influenza like illness, Nasopharyngitis
Clinical narrative: felt like she was catching a cold; Diarrhea; Flu like symptoms; Hot & Cold; Achy all over the body; Hot & Cold Sweats; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (felt like she was catching a cold), DIARRHEA (Diarrhea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (Hot & Cold) and PAIN IN EXTREMITY (Achy all over the body) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NASOPHARYNGITIS (felt like she was catching a cold), DIARRHEA (Diarrhea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (Hot & Cold), PAIN IN EXTREMITY (Achy all over the body) and HYPERHIDROSIS (Hot & Cold Sweats). At the time of the report, NASOPHARYNGITIS (felt like she was catching a cold), DIARRHEA (Diarrhea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (Hot & Cold), PAIN IN EXTREMITY (Achy all over the body) and HYPERHIDROSIS (Hot & Cold Sweats) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details not provided
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: felt like she was catching a cold; Diarrhea; Flu like symptoms; Hot & Cold; Achy all over the body; Hot & Cold Sweats; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (felt like she was catching a cold), DIARRHEA (Diarrhea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (Hot & Cold) and PAIN IN EXTREMITY (Achy all over the body) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NASOPHARYNGITIS (felt like she was catching a cold), DIARRHEA (Diarrhea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (Hot & Cold), PAIN IN EXTREMITY (Achy all over the body) and HYPERHIDROSIS (Hot & Cold Sweats). At the time of the report, NASOPHARYNGITIS (felt like she was catching a cold), DIARRHEA (Diarrhea), INFLUENZA LIKE ILLNESS (Flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (Hot & Cold), PAIN IN EXTREMITY (Achy all over the body) and HYPERHIDROSIS (Hot & Cold Sweats) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details not provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Appointment date for second vaccination will be 48 days out; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Appointment date for second vaccination will be 48 days out) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Appointment date for second vaccination will be 48 days out). On 26-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Appointment date for second vaccination will be 48 days out) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment details was not provided.   The patient stated that she was not able to get a call back for the second vaccination appointment until the 29th Mar 2021 and got the date on 15 Apr 2021. The patient also reports that the first vaccination was done at a mass injection site.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache
Clinical narrative: Diarrhea; Fatigue; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and HEADACHE (Headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and HEADACHE (Headaches). At the time of the report, DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include (Pepto-Bismol) and yogurt in order to mitigate the diarrhea. No concomitant medication reported
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Body temperature, Dehydration, Fatigue, Heart rate
Clinical narrative: blood pressure went up and down; heart rate slow down to 50; was very very thirsty; could not stop her nose from running; everything in her body hurt; fever went up to 97 and it started dropping; Fatigue; muscle aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLOOD PRESSURE ABNORMAL (blood pressure went up and down), HEART RATE DECREASED (heart rate slow down to 50), DEHYDRATION (was very very thirsty), RHINORRHOEA (could not stop her nose from running) and PAIN IN EXTREMITY (everything in her body hurt) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M210A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (blood pressure went up and down), HEART RATE DECREASED (heart rate slow down to 50), DEHYDRATION (was very very thirsty), RHINORRHOEA (could not stop her nose from running), PAIN IN EXTREMITY (everything in her body hurt), PYREXIA (fever went up to 97 and it started dropping), FATIGUE (Fatigue) and MYALGIA (muscle aches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BLOOD PRESSURE ABNORMAL (blood pressure went up and down), HEART RATE DECREASED (heart rate slow down to 50), DEHYDRATION (was very very thirsty), RHINORRHOEA (could not stop her nose from running), PAIN IN EXTREMITY (everything in her body hurt), PYREXIA (fever went up to 97 and it started dropping), FATIGUE (Fatigue) and MYALGIA (muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 97 (Inconclusive) Inconclusive. On an unknown date, Heart rate: 50 (Low) Low.         Concomitant medications were not reported.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate decreased, Myalgia, Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: blood pressure went up and down; heart rate slow down to 50; was very very thirsty; could not stop her nose from running; everything in her body hurt; fever went up to 97 and it started dropping; Fatigue; muscle aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLOOD PRESSURE ABNORMAL (blood pressure went up and down), HEART RATE DECREASED (heart rate slow down to 50), DEHYDRATION (was very very thirsty), RHINORRHOEA (could not stop her nose from running) and PAIN IN EXTREMITY (everything in her body hurt) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M210A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE ABNORMAL (blood pressure went up and down), HEART RATE DECREASED (heart rate slow down to 50), DEHYDRATION (was very very thirsty), RHINORRHOEA (could not stop her nose from running), PAIN IN EXTREMITY (everything in her body hurt), PYREXIA (fever went up to 97 and it started dropping), FATIGUE (Fatigue) and MYALGIA (muscle aches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BLOOD PRESSURE ABNORMAL (blood pressure went up and down), HEART RATE DECREASED (heart rate slow down to 50), DEHYDRATION (was very very thirsty), RHINORRHOEA (could not stop her nose from running), PAIN IN EXTREMITY (everything in her body hurt), PYREXIA (fever went up to 97 and it started dropping), FATIGUE (Fatigue) and MYALGIA (muscle aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 97 (Inconclusive) Inconclusive. On an unknown date, Heart rate: 50 (Low) Low.         Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Neck pain, Tenderness
Clinical narrative: sharp pain in right neck radiating down to her clavicle and upper right arm; tenderness when she touch her humerus bone; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (sharp pain in right neck radiating down to her clavicle and upper right arm), TENDERNESS (tenderness when she touch her humerus bone) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced NECK PAIN (sharp pain in right neck radiating down to her clavicle and upper right arm), TENDERNESS (tenderness when she touch her humerus bone) and CHILLS (Chills). At the time of the report, NECK PAIN (sharp pain in right neck radiating down to her clavicle and upper right arm), TENDERNESS (tenderness when she touch her humerus bone) and CHILLS (Chills) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medications and treatment information were reported.